News Detail
New Delhi, 7 March 2025: The National Pharmaceutical Pricing Authority (NPPA) has notified the retail price of 53 new drugs based on applications submitted by individual companies, after finalising the same in the latest meeting.
Over one third of the formulations for ......
View Details
Source : Pharmabiz
NPPA
retail price
new drugs
formulations
anti-diabetes formulations
empagliflozin
Boehringer Ingelheim
metformin hydrochloride
Zydus
Alkem Laboratories
Morepen Laboratories
USV
Cadila Pharmaceuticals
Emcure Pharmaceuticals
Abbott Healthcare
Intas Pharmaceuticals
dapagliflozin
sitagliptin
linagliptin
vildagliptin
teneligliptin
Ajanta Pharma
Cipla
Blue Cross Laboratories
Akumentis Healthcare
Primus Remedies
Related News
- Karnataka notifies NDPS Rules, Essential Narcotic Drugs to be regulated under Central Rules (22-03-2025)
- One hundred teams participated in 'Operation Garuda', uncovering nearly 40 different types of drugs being sold without prescriptions (22-03-2025)
- List of OTC drugs to be Submitted to Govt Soon: Panel Chief (21-03-2025)
- DCA seized four medicines for misleading 'Leucoderma', 'Tuberculosis' and 'Fever' treatment claims (21-03-2025)
- Skin specialists flag widespread quackery in Kerala (21-03-2025)
- SHRC orders criminal proceedings against fake doctor (21-03-2025)
- Gujarat HC stays GST action against Gujarat Medical Council, other boards (21-03-2025)
- CEPI and AstraZeneca to advance discovery into novel antibody (21-03-2025)
- FIR against 3 animal husbandry dept officials booked for sending damaged vaccine to Hospitals (21-03-2025)
- Eli Lilly launches blockbuster anti-obesity drug Mounjaro in India (20-03-2025)